021-54156088
當(dāng)前位置:圣賓儀器科技(上海)有限公司 > 產(chǎn)品中心 > 化學(xué)試劑標(biāo)準(zhǔn)品 > 藥物雜質(zhì)標(biāo)準(zhǔn)品 > USP美國藥典標(biāo)準(zhǔn)品一級(jí)代理,USP標(biāo)準(zhǔn)物質(zhì)報(bào)價(jià)
聯(lián)系人:程先生
電 話:021-54156088
手 機(jī):15202161235
地 址:上海市閔行區(qū)滬光東路88號(hào)203-205室
郵 編:201108
傳 真:021-54161159
郵 箱:ch@shengbinyq.com
阿儀網(wǎng)商鋪:http://www.app17.com/c124399/
手機(jī)網(wǎng)站:m.shengbin-sh.com
價(jià)格:電議
采購度:1118 原產(chǎn)地:美洲
發(fā)布時(shí)間:2018/4/11 17:14:04
標(biāo)簽:USP美國藥典標(biāo)準(zhǔn)品一級(jí)代理 USP標(biāo)準(zhǔn)物質(zhì)報(bào)價(jià) 美國USP標(biāo)準(zhǔn)品價(jià)格 USP藥典標(biāo)準(zhǔn)品總代理
1198000 Digitalis (3 g) F [8031-42-3] | ||||||||||||
1199002 Digitoxin (200 mg) M [71-63-6] | ||||||||||||
1200000 Digoxin (250 mg) O0B096 N-1 (04/03) [20830-75-5] | ||||||||||||
1200600 Dihydrocapsaicin (25 mg) H0F210 1.00 mg/mg (ai) G0C071 (09/07)F-1 (12/03)F (01/00)[19408-84-5] | ||||||||||||
1200804 Dihydrocodeine Bitartrate CII (200 mg) I0D205 0.997 mg/mg (dr) H (09/05)G (03/01)[5965-13-9] | ||||||||||||
1201002 17alpha-Dihydroequilin (50 mg) I0C277 H (07/04) [6639-99-2] | ||||||||||||
1202005 Dihydroergotamine Mesylate (250 mg) (List Chemical)J0B085 I (03/03) [6190-39-2] | ||||||||||||
1203008 Dihydrostreptomycin Sulfate (200 mg) J [5490-27-7] | ||||||||||||
1204000 Dihydrotachysterol (30 mg/ampule; 4 ampules) J0D250 0.996 mg/mg (ai) I (06/05) [67-96-9] | ||||||||||||
1204102 Dihydroxyacetone (250 mg) F [96-26-4] | ||||||||||||
1204805 Diloxanide Furoate (200 mg) F0C026 [3736-81-0] | ||||||||||||
1205003 Diltiazem Hydrochloride (200 mg) J0F005 0.999 mg/mg (dr) 2 I (11/07) [33286-22-5] | ||||||||||||
1206006 Dimenhydrinate (100 mg) J0B055 I (06/03) [523-87-5] | ||||||||||||
1208001 Dimethisoquin Hydrochloride (2 g) G [2773-92-4] | ||||||||||||
1210105 N-(3-Dimethylamino-propyl)-2-aza-8,8-diethyl-8-germaspiro [4:5]decane-1,3-dione (AS) DISCONTINUED F (10/07) [41992-23-8] | ||||||||||||
1211006 Dimethyl Sulfoxide (3 g) H0D273 0.999 mg/mg (ai) G0C198 (10/06)F-3 (07/04)F-2 (05/02)[67-68-5] | ||||||||||||
1213001 Dinoprost Tromethamine (50 mg) F [38562-01-5] | ||||||||||||
1213103 Dinoprostone (50 mg) F0C030 [363-24-6] | ||||||||||||
1214004 Dioxybenzone (150 mg) F1B277 F (10/03) [131-53-3] | ||||||||||||
1217909 Diphenhydramine Citrate (125 mg) H1C350 1.000 mg/mg (dr) H0B128 (08/06)G (04/03)[88637-37-0] | ||||||||||||
1218005 Diphenhydramine Hydrochloride (200 mg) J0B013 I (07/03) [147-24-0] | ||||||||||||
1219008 Diphenoxylate Hydrochloride CII (200 mg) I1D339 0.998 mg/mg (dr) I (08/06)H (03/02)[3810-80-8] | ||||||||||||
1220302 Dipivefrin Hydrochloride (200 mg) I H (06/99) [64019-93-8] | ||||||||||||
1220506 Dipyridamole (200 mg) H1F120 0.998 mg/mg (dr) H (06/07)G-1 (01/99)[58-32-2] | ||||||||||||
1220700 Dirithromycin (200 mg) F [62013-04-1] | ||||||||||||
1221000 Disodium Guanylate (300 mg) (FCC) F-1 [5550-12-9] | ||||||||||||
1222002 Disodium Inosinate (500 mg) (FCC) F [4691-65-0] | ||||||||||||
1222501 Disopyramide Phosphate (200 mg) I0E337 1.000 mg/mg (dr) H-1 (08/07)H (03/02)[22059-60-5] | ||||||||||||
1223005 2,4-Disulfamyl-5-trifluoromethylaniline (125 mg) G [654-62-6] | ||||||||||||
1224008 Disulfiram (200 mg) F-3 F-2 (07/02) [97-77-8] | ||||||||||||
1224507 Dobutamine Hydrochloride (600 mg) H-1 H (01/00) [49745-95-1] | ||||||||||||
1224664 Docosyl Ferulate (50 mg) F0E143 0.99 mg/mg (ai) 1 [101927-24-6] | ||||||||||||
1224700 Docusate Calcium (500 mg) H0B044 G-1 (07/02) [128-49-4] | ||||||||||||
1224802 Docusate Sodium (500 mg) K0D134 0.988mg/mg (an) J (09/05)I-1 (05/02)[577-11-7] | ||||||||||||
1224904 Docusate Potassium (100 mg) F-1 F (11/99) [7491-09-0] | ||||||||||||
1224959 Dolasetron Mesylate (200 mg) F0C319 [115956-13-3] | ||||||||||||
1224960 Dolasetron Mesylate Related Compound A (25 mg) (Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one hydrochloride) F0C321 n/f | ||||||||||||
1225204 Dopamine Hydrochloride (200 mg) G F-5 (05/02) [62-31-7] | ||||||||||||
1225281 Dorzolamide Hydrochloride (200 mg) G0E278 0.998 mg/mg (ai) F0C040 (11/06) [130693-82-2] | ||||||||||||
1225292 Dorzolamide Hydrochloride Related Compound A (20 mg) ((4R,6R)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide, monohydrochloride) G0E029 F0C068 (12/05) n/f | ||||||||||||
1225000 Doxapram Hydrochloride (200 mg) F4C053 F-3 (07/04) [7081-53-0] | ||||||||||||
1225419 Doxazosin Mesylate (200 mg) G0E173 0.997 mg/mg (ai) F0C079 (08/06) [77883-43-3] | ||||||||||||
1225500 Doxepin Hydrochloride (500 mg) I [1229-29-4] | ||||||||||||
1225703 Doxorubicin Hydrochloride (50 mg) K J (06/02) [25316-40-9] | ||||||||||||
1226003 Doxycycline Hyclate (200 mg) J0E174 859 ug/mg (ai ) (chromatographic) 864 ug/mg ( a i ) (spectroscopic) I (09/06)H (01/00)[24390-14-5] | ||||||||||||
1227006 Doxylamine Succinate (300 mg) I1F141 0.998 mg/mg (ai) I0B266 (10/07)H (01/04)[562-10-7] | ||||||||||||
1229001 Droperidol (250 mg) I0C029 H-1 (01/05)H (04/99)[548-73-2] | ||||||||||||
1230000 Dyclonine Hydrochloride (200 mg) G [536-43-6] | ||||||||||||
1231003 Dydrogesterone (200 mg) I0B114 H (01/04) [152-62-5] | ||||||||||||
1231502 Dyphylline (200 mg) G-2 G-1 (11/02) [479-18-5] | ||||||||||||
1231728 Powdered Echinacea Purpurea Extract (1 g) F0D018 [90028-20-9] | ||||||||||||
1231706 Powdered Echinacea Angustifolia Extract (1 g) F0D019 [84696-11-7] | ||||||||||||
1231808 Econazole Nitrate (200 mg) G1C346 1.00 mg/mg (ai) G (07/05) [68797-31-9] | ||||||||||||
1232006 Edetate Calcium Disodium (200 mg) H0B272 G-3 (11/04)G-2 (11/99)[23411-34-9] | ||||||||||||
1233009 Edetate Disodium (200 mg) I0D405 H (06/06)G-2 (04/02)[6381-92-6] | ||||||||||||
1233508 Edetic Acid (200 mg) F-1 [60-00-4] USP美國藥典標(biāo)準(zhǔn)品一級(jí)代理,USP標(biāo)準(zhǔn)物質(zhì)報(bào)價(jià) | ||||||||||||
1234001 Edrophonium Chloride (200 mg) H G (08/99) [116-38-1] | ||||||||||||
1234704 Powdered Eleuthero Extract (1.5 g) F0C291 [84696-12-5] | ||||||||||||
1234668 Eleutheroside B (15 mg) (Syringin) F0E056 95% (ai) [118-34-3] | ||||||||||||
1234680 Eleutheroside E (15 mg) (Syringaresinol diglucoside)F0E057 98% (ai) [96038-87-8] | ||||||||||||
1234806 Emedastine Difumarate (100 mg) F0C059 [87233-62-3] | ||||||||||||
1235004 Emetine Hydrochloride (300 mg) H0B201 G (05/03) [316-42-7] | ||||||||||||
1235274 Enalaprilat (300 mg) J0C268 I (11/04)H (03/01)G (08/99)[84680-54-6] | ||||||||||||
1235300 Enalapril Maleate (200 mg) J1C267 0.992 mg/mg (ai) J (05/05)I (06/01)[76095-16-4] | ||||||||||||
1235503 Endotoxin (10,000 USP Endotoxin Units) G3E069 G2B274 (06/06)G-1 (12/03)G (06/99)n/f | ||||||||||||
1235809 Enflurane (1 mL) G-1 G (02/01) [13838-16-9] | ||||||||||||
1235900 Enrofloxacin (200 mg) (AS) F0E094 [93106-60-6] | ||||||||||||
1236007 Ephedrine Sulfate (200 mg) (List Chemical) H-2 H-1 (11/02) [134-72-5] | ||||||||||||
1236506 4-Epianhydrotetracycline Hydrochloride (50 mg) J0C041 I-1 (12/03)I (06/00)[4465-65-0] | ||||||||||||
1236801 Epilactose (200 mg) H0E049 1.00 mg/mg (dr) G (08/06)F-1 (06/00)[50468-56-9] | ||||||||||||
1237000 Epinephrine Bitartrate (200 mg) P0E320 0.998 mg/mg (ai) O (05/07) [51-42-3] | ||||||||||||
1237509 Epitetracycline Hydrochloride (200 mg) (AS) G0E261 F (12/06) [23313-80-6] | ||||||||||||
1238002 Equilin (25 mg) I1B290 I (11/04)H-1 (05/00)[474-86-2] | ||||||||||||
1239005 Ergocalciferol (30 mg/ampule; 5 ampules) (Vitamin D2) P0B275 O (02/04)N (12/99)[50-14-6] | ||||||||||||
1239504 Ergoloid Mesylates (300 mg) I H-1 (01/00) [8067-24-1] | ||||||||||||
1240004 Ergonovine Maleate (100 mg) (List Chemical) N M-1 (07/02) [129-51-1] | ||||||||||||
1241007 Ergosterol (50 mg) H [57-87-4] | ||||||||||||
1241506 Ergotamine Tartrate (150 mg) (List Chemical) I0B174 H (01/04) [379-79-3] | ||||||||||||
1241550 Ergotaminine (100 mg) (List Chemical) G0B177 F-1 (06/04) [639-81-6] | ||||||||||||
1241903 Erythritol (200 mg) F0E313 [149-32-6] | ||||||||||||
1242000 Erythromycin (250 mg) M1E251 96.7% Erythromycin A 978 ug/mg (ai)(microbial)M (02/07)L (08/99)[114-07-8] | ||||||||||||
1242010 Erythromycin B (150 mg) G1C080 G (11/04)F-1 (09/01)F (05/01)[527-75-3] | ||||||||||||
1242021 Erythromycin C (50 mg) F-3 F-2 (01/03)F-1 (02/02)F (02/99)n/f | ||||||||||||
1242032 Erythromycin Related Compound N (50 mg) (NDemethylerythromycin A) F2A023 F-1 (06/04)F (09/99)n/f | ||||||||||||
1243002 Erythromycin Estolate (200 mg) H G (01/03) [3521-62-8] | ||||||||||||
1245008 Erythromycin Ethylsuccinate (200 mg) H G-1 (06/01) [1264-62-6] | ||||||||||||
1246000 Erythromycin Gluceptate (200 mg) H G (07/03) [23067-13-2] | ||||||||||||
1247003 Erythromycin Lactobionate (200 mg) H-1 H (01/02) [3847-29-8] | ||||||||||||
1248006 Erythromycin Stearate (200 mg) H0B187 G-1 (05/03) [643-22-1] | ||||||||||||
1249009 Erythrosine Sodium (100 mg) F [49746-10-3] | ||||||||||||
1249202 Escin (350 mg) F0F088 0.999 mg/mg (an) [11072-93-8] | ||||||||||||
1250008 Estradiol (500 mg) M0E309 0.999 mg/mg (an) L0C337 (03/07)K1B007 (07/05)K (04/03)[50-28-2] | ||||||||||||
1251000 Estradiol Benzoate (250 mg) (AS) H0C332 G-1 (01/06) [50-50-0] | ||||||||||||
1252003 Estradiol Cypionate (200 mg) G-1 G (02/00) [313-06-4] | ||||||||||||
1254009 Estradiol Valerate (100 mg) L1D286 0.996 mg/mg (ai) L (04/06)K (05/02)[979-32-8] | ||||||||||||
1254508 Estriol (100 mg) J I-1 (06/01) [50-27-1] | ||||||||||||
1255001 Estrone (200 mg) L0F119 0.999 mg/mg (ai) K1B099 (07/07)K (07/03)J-1 (07/00)[53-16-7] | ||||||||||||
1255500 Estropipate (500 mg) J0B262 I (12/03)H (09/01)[7280-37-7] | ||||||||||||
1256004 Ethacrynic Acid (200 mg) F [58-54-8] | ||||||||||||
1257007 Ethambutol Hydrochloride (200 mg) H G (08/02) [1070-11-7] | ||||||||||||
1258305 Ethchlorvynol CIV (0.7 ml) F0B011 [113-18-8] | ||||||||||||
1260001 Ethinyl Estradiol (150 mg) Q0C162 P1B193 (11/04)P0B052 (01/04)P (03/03)O (08/99)[57-63-6] | ||||||||||||
1260012 Ethinyl Estradiol Related Compound A (20 mg)(6-Keto-ethinyl estradiol)G0E301 0.99 mg/mg (ai) F0B252 (04/07) n/f | ||||||||||||
1261004 Ethionamide (200 mg) H0B148 G (03/03) [536-33-4] | ||||||||||||
1262801 Ethopabate (125 mg) F [59-06-3] | ||||||||||||
1262823 Ethopabate Related Compound A (25 mg)(Methyl-4-acetamido-2-hydroxybenzoate)F n/f | ||||||||||||
1263000 Ethopropazine Hydrochloride (300 mg) G [1094-08-2] | ||||||||||||
1264002 Ethosuximide (125 mg) H G-2 (11/01)G-1 (05/99)[77-67-8] | ||||||||||||
1264501 Ethotoin (200 mg) F [86-35-1] | ||||||||||||
1265005 Ethoxzolamide (200 mg) F [452-35-7] | ||||||||||||
1265402 Ethyl Acetate (1.2 mL/ampule; 3 ampules) F0E282 1.00 mg/mg (ai) [141-78-6] | ||||||||||||
1265504 Ethylcellulose (1 g) H-1 H (06/99) [9004-57-3] | ||||||||||||
1265606 Ethyl Formate (1.2 mL/ampule; 3 ampules) F0E193 0.99 mg/mg (ai) [109-94-4] | ||||||||||||
1266008 Ethyl Maltol (1 g) (FCC) H [4940-11-8] | ||||||||||||
1266507 Ethylnorepinephrine Hydrochloride (200 mg) F [3198-07-0] | ||||||||||||
1267000 Ethylparaben (200 mg) I1F039 I0A016 (05/07)H (01/04)[120-47-8] | ||||||||||||
1267500 Ethyl Vanillin (200 mg) F2B134 F-1 (04/04) [121-32-4] | ||||||||||||
1268003 Ethynodiol Diacetate (200 mg) I0A033 H-1 (01/03)H (04/01)[297-76-7] | ||||||||||||
1268502 Etidronate Disodium (200 mg) G F-2 (02/03) [7414-83-7] | ||||||||||||
1268513 Etidronate Disodium Related Compound A (300 mg) (Sodium phosphite dibasic pentahydrate) F0E227 1.00 mg/mg (an) [13517-23-2] | ||||||||||||
1268604 Etidronic Acid Monohydrate (1 g) G F-1 (05/99) [2809-21-4] | ||||||||||||
1268706 Etodolac (400 mg) G F (10/01) [41340-25-4] | ||||||||||||
1268728 Etodolac Related Compound A (25 mg) ((+/-)-8-ethyl-1-methyl-1,3,4,9-tetrahydropyrano [3,4-b]-indole-1-acetic acid) F-1 F (05/02) [109518-50-5] | ||||||||||||
1268808 Etoposide (300 mg) H0C315 G (11/04) [33419-42-0] | ||||||||||||
1268852 Etoposide Resolution Mixture (30 mg) F0B209 [33419-42-0] | ||||||||||||
1268965 Eugenol (500 mg) (AS) F0D303 [97-53-0] | ||||||||||||
1269200 Famotidine (125 mg) I0E063 0.997 mg/mg (dr) H-1 (06/06)H (11/02)G (03/99)[76824-35-6] | ||||||||||||
1269389 Felodipine (200 mg) G0D065 0.999 mg/mg (ai) F-1 (04/05)F (09/02)[72509-76-3] | ||||||||||||
1269390 Felodipine Related Compound A (100 mg) (ethyl methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate) F0B207 [96302-71-7] | ||||||||||||
1269403 Fenbendazole (100 mg) F [43210-67-9] | ||||||||||||
1269414 Fenbendazole Related Compound A (30 mg)(Methyl (1H-benzimidazole-2-yl)carbamate) F0D009 0.99 mg/mg (ai) [10605-21-7] | ||||||||||||
1269425 Fenbendazole Related Compound B (30 mg)(Methyl [5(6)-chlorobenzimidazole-2-yl]carbamate) F0D008 0.99 mg/mg (ai) n/f | ||||||||||||
1269447 Fenofibrate (200 mg) F0F020 0.999 mg/mg (ai) [49562-28-9] | ||||||||||||
1269607 Fenofibrate Related Compound A (25 mg) ((4-chlorophenyl)(4-hydroxyphenyl)metha) F0F021 1.00 mg/mg (ai) [42019-78-3] | ||||||||||||
1269618 Fenofibrate Related Compound B (25 mg) (2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid)F0F022 1.00 mg/mg (ai) [42017-89-0] | ||||||||||||
1269629 Fenofibrate Related Compound C (25 mg) (1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy]-2-methylpropanoate) F0F023 1.00 mg/mg (ai) [217636-48-1] | ||||||||||||
1269458 Fenoldopam Mesylate (200 mg) F0C125 [67227-57-0] | ||||||||||||
1269469 Fenoldopam Related Compound A (20 mg) (NMethyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol hydrochloride) F0C124 n/f | ||||||||||||
1269470 Fenoldopam Related Compound B (20 mg) (1H-3-Benzazapine-7,8-diol, 2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, methanesulfonate) F0C126 n/f | ||||||||||||
1269505 Fenoprofen Calcium (500 mg) G-1 [53746-45-5] USP美國藥典標(biāo)準(zhǔn)品一級(jí)代理,USP標(biāo)準(zhǔn)物質(zhì)報(bào)價(jià) | ||||||||||||
1269550 Fenoprofen Sodium (500 mg) G F-1 (05/02) [66424-46-2] | ||||||||||||
1270355 Ferrous Sulfate (1.5 g) (AS) F0D196 101.0% (ai) [7782-63-0] | ||||||||||||
1270005 Fentanyl Citrate CII (100 mg) K0C264 J2B227 (11/04) J-1 (09/03)J (05/02)I (06/00)[990-73-8] | ||||||||||||
1270377 Fexofenadine Hydrochloride (200 mg) F1E289 0.996 mg/mg (ai) F0D244 (02/07) [138452-21-8] | ||||||||||||
1270388 Fexofenadine Related Compound A (25 mg) (4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl benzeneacetic acid) F0D245 0.99 mg/mg (ai) n/f | ||||||||||||
1270399 Fexofenadine Related Compound B (25 mg) (3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl benzeneacetic acid hydrochloride) F0D246 n/f | ||||||||||||
1270446 Fexofenadine Related Compound C (15 mg) ((+)-4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-isopropylbenzene) (AS) F0E291 n/f | ||||||||||||
1270402 Finasteride (200 mg) F1E139 0.997 mg/mg (ai) F (07/06) [98319-26-7] | ||||||||||||
1270800 Flecainide Acetate (200 mg) F2A022 F-1 (02/05) F (06/03)[54143-56-5] | ||||||||||||
1270821 Flecainide Related Compound A (75 mg) (3-[2,5-bis(2,2 ,2 - t r i fl uoroethoxy)phenyl] -1,5,6,7,8,8a-hexahydroimidazo-[1,5a]pyridine Hydrochloride) F n/f | ||||||||||||
1271008 Floxuridine (250 mg) G0F207 1.000 mg/mg (dr) F-2 (09/07)F-1 (08/01)[50-91-9] | ||||||||||||
1271700 Fluconazole (200 mg) G0F102 1.00 mg/mg (ai) F0D262 (06/07) [86386-73-4] | ||||||||||||
1271711 Fluconazole Related Compound A (10 mg) (2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol) G0F201 0.99 mg/mg (ai) F0D080 (08/07) n/f | ||||||||||||
1271722 Fluconazole Related Compound B (10 mg) (2-(4-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol) G0F218 0.94 mg/mg (ai) F0D081 (09/07) [81886-51-3] | ||||||||||||
1271733 Fluconazole Related Compound C (10 mg) (1,1’-(1,3-phenylene)di(1H-1,2,4-triazole)) G0F202 0.99 mg/mg (ai) 2 F0D082 (12/07) n/f | ||||||||||||
1272000 Flucytosine (200 mg) G0E151 1.000 mg/mg (dr) F (06/05) [2022-85-7] | ||||||||||||
1272204 Fludarabine Phosphate (300 mg) G0E247 0.993 mg/mg (an) F0C374 (04/07) [75607-67-9] | ||||||||||||
1272907 Fludeoxyglucose (100 mg) F0E100 [29702-43-0] | ||||||||||||
1272918 Fludeoxyglucose Related Compound A (15 mg) (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane) F0D119 1.00 mg/mg (ai) [23978-09-8] | ||||||||||||
1273003 Fludrocortisone Acetate (250 mg) H G (08/01) [514-36-3] | ||||||||||||
1273808 Flumazenil (200 mg) F0C305 [78755-81-4] | ||||||||||||
1273819 Flumazenil Related Compound A (20 mg) (8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha][1,4]benzodiazepine-3-carboxylic acid) F0E147 n/f | ||||||||||||
1273820 Flumazenil Related Compound B (20 mg) (Ethyl 8-hydroxy-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha][1,4]benzodiazepine-3-carboxylate) F0E148 n/f | ||||||||||||
1274006 Flumethasone Pivalate (200 mg) I H (01/02) [2002-29-1] | ||||||||||||
1274505 Flunisolide (200 mg) I H (01/01) [77326-96-6] | ||||||||||||
1274607 Flunixin Meglumine (300 mg) H0E241 1.000 mg/mg (dr) G (11/06)F-1 (04/02)F (09/99)[42461-84-7] | ||||||||||||
1275009 Fluocinolone Acetonide (100 mg) J1E014 0.993 mg/mg (dr) J (03/06)I (11/99)[67-73-2] | ||||||||||||
1276001 Fluocinonide (100 mg) I [356-12-7] | ||||||||||||
1277004 Fluorescein (200 mg) G0B171 F-1 (02/03) [2321-07-5] | ||||||||||||
1277252 Fluoride Dentifrice: Sodium Fluoride/Silica (4.5 oz) K0F055 J0C294 (06/07)I (08/04)H (04/99)n/f | ||||||||||||
1277274 Fluoride Dentifrice: Sodium Fluoride/Sodium Bicarbonate Powder (4 oz) G0D270 F (06/05) n/f | ||||||||||||
1277300 Fluoride Dentifrice: Sodium Monofluorophosphate-Calcium Carbonate (4.6 oz) G n/f | ||||||||||||
1277354 Fluoride Dentifrice: Sodium Monofluorophosphate/Dicalcium Phosphate (4.6 oz) G n/f | ||||||||||||
1277401 Fluoride Dentifrice: Sodium Monofluorophosphate(1000 ppm)/Silica (5.25 oz) G-1 G (08/99) n/f | ||||||||||||
1277423 Fluoride Dentifrice: Sodium Monofluorophosphate(1500 ppm)/Silica (5.25 oz) F-1 F (07/99) n/f | ||||||||||||
1277456 Fluoride Dentifrice: Stannous Fluoride-Silica (4 oz) H0B105 G (11/02) n/f | ||||||||||||
1278007 Fluorometholone (200 mg) J0F140 0.996 mg/mg (ai) I0B184 (06/07) H-1 (11/02) [426-13-1] | ||||||||||||
1278109 Fluorometholone Acetate (200 mg) F [3801-06-7] | ||||||||||||
1278302 Fluoroquinolonic Acid (50 mg) H0C140 G (01/05)F-1 (12/99)[86393-33-1] | ||||||||||||
1279000 Fluorouracil (250 mg) H2D190 1.000 mg/mg (dr) H-1 (09/05)H (01/02)[51-21-8] | ||||||||||||
1279804 Fluoxetine Hydrochloride (200 mg) G0F085 0.999 mg/mg (ai) F2C132 (06/07)F-1 (02/05)F (11/99)[59333-67-4] | ||||||||||||
1279815 Fluoxetine Related Compound A (15 mg) (Nmethyl-3-phenyl-3-[(alpha,alpha,alpha-(trifluorom-tolyl)oxy]propylamine Hydrochloride) H0C131 G (06/04)F-1 (05/01)F (06/00)n/f | ||||||||||||
1279826 Fluoxetine Related Compound B (5 mL of a 0.01N HCl solution, approx. 2 mg/mL) (Nmethyl-3-phenylpropylamine) G0D023 approx. 2 mg/mL(ai) F3C085 (05/05)F-2 (06/04)F-1 (09/02)F (09/00)[23580-89-4] | ||||||||||||
1279837 Fluoxetine Related Compound C (15 mg) (NMethyl-N-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-succinamic acid) F0C352 n/f | ||||||||||||
1280009 Fluoxymesterone CIII (200 mg) G-2 (11/07) G-1 (04/00)[76-43-7] | ||||||||||||
1280803 Fluphenazine Decanoate Dihydrochloride (500 mg) G F-1 (10/01) n/f | ||||||||||||
1281001 Fluphenazine Enanthate Dihydrochloride (125 mg) H G (02/99) [3105-68-8] | ||||||||||||
1282004 Fluphenazine Hydrochloride (125 mg) H [146-56-5] | ||||||||||||
1284000 Flurandrenolide (100 mg) I0B245 H (09/03) [1524-88-5] | ||||||||||||
1285002 Flurazepam Hydrochloride CIV (200 mg) J0C365 0.996 mg/mg (ai) I (09/03) [1172-18-5] | ||||||||||||
1285308 Flurazepam Related Compound C (50 mg) (5-chloro-2-(2-diethylaminoethylamino)-2’-fluorobenzophe Hydrochloride) I0D361 1.00 mg/mg (ai) H-1 (04/06) n/f | ||||||||||||
1285603 Flurazepam Related Compound F (50 mg) (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one) I0C092 H (01/04) [2886-65-9] | ||||||||||||
1285750 Flurbiprofen (200 mg) H0D349 0.994 mg/mg (ai) G (01/06) [5104-49-4] | ||||||||||||
1285760 Flurbiprofen Related Compound A (100 mg) (2-(4-Biphenylyl)propionic Acid) H G (03/01) n/f | ||||||||||||
1285807 Flurbiprofen Sodium (200 mg) F [56767-76-1] | ||||||||||||
1285851 Flutamide (200 mg) H1E297 1.000 mg/mg (dr) H0B278 (09/07)G (11/04)F-1 (06/00)[13311-84-7] | ||||||||||||
1285862 o-Flutamide (50 mg) F-1 F (01/00) n/f | ||||||||||||
1285873 Fluticasone Propionate (100 mg) F0F036 0.989 mg/mg (ai) [80474-14-2] | ||||||||||||
1285884 Fluticasone Propionate Resolution Mixture (25 mg) F0E123 n/f | ||||||||||||
1285895 Fluticasone Propionate System Suitability Mixture (25 mg) (Fluticasone Propionate and Fluticasone Propionate Related Compounds B, C and D) F0E122 n/f | ||||||||||||
1285931 Fluvastatin Sodium (350 mg) F0F015 0.997 mg/mg (ai) [93957-55-2] | ||||||||||||
1285964 Fluvastatin Related Compound B (15 mg) ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1, dimethylethyl ester) F0F017 [129332-29-2] | ||||||||||||
1285942 Fluvastatin for System Suitability (25 mg) (Fluvastatin sodium and fluvastatin sodium antiisomer ([R*,R*-E]-(+/-)-7-[3-(4-Fluorophenyl)-1-(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt)) F0F016 n/f | ||||||||||||
1285909 Fluvoxamine Maleate (200 mg) F0E016 0.996 mg/mg (dr) [61718-82-9] | ||||||||||||
1286005 Folic Acid (500 mg) (Vitamin M or Vitamin Bc) P O (07/00) [59-30-3] | ||||||||||||
1286027 Folic Acid Related Compound A (50 mg) (Calcium Formyltetrahydrofolate) I0B176 H-1 (04/04)H (01/00)[1492-18-8] | ||||||||||||
1286060 Formotin (50 mg) F0C196 [485-72-3] | ||||||||||||
1286300 10-Formylfolic Acid (25 mg) F2B226 F-1 (01/04) [134-05-4] | ||||||||||||
1286366 Fosphenytoin Sodium (250 mg) G0E124 0.999 mg/mg (an) F0C156 (07/06) [92134-98-0] | ||||||||||||
1286504 Fructose (125 mg) I3E340 0.999 mg/mg (ai) I-2 (04/07) I-1 (11/02)I (08/99)[57-48-7] | ||||||||||||
1286606 L-Fucose (200 mg) (AS) F0E007 [2438-80-4] | ||||||||||||
1286708 Fumaric Acid (200 mg) H0E328 1.00 mg/mg (ai) G-1 (03/07)G (04/02)[110-17-8] |
更新時(shí)間:2024/5/14 18:43:24
您感興趣的產(chǎn)品* | 您還沒有輸入您感興趣的產(chǎn)品 | |
您的單位* | 您還沒有輸入您的單位 | |
聯(lián)系人* | 您還沒有輸入聯(lián)系人 | |
聯(lián)系電話* | 您還沒有輸入聯(lián)系電話 | |
詳細(xì)地址 | ||
常用郵箱 | 您輸入的郵箱格式不正確 | |
請(qǐng)輸入您對(duì)我們的意見或建議* | 您還沒有輸入您對(duì)我們的意見或建議 | |
驗(yàn)證碼* | 您還沒有輸入驗(yàn)證碼 |
溫馨提示
1.遵守中華人民共和國有關(guān)法律、法規(guī),尊重網(wǎng)上道德,承擔(dān)一切因您的行為而直接或間接引起的法律責(zé)任。
2.請(qǐng)您真實(shí)的反映產(chǎn)品的情況,不要捏造、誣蔑、造謠。如對(duì)產(chǎn)品有任何疑問,也可以留言咨詢。
3.未經(jīng)本站同意,任何人不得利用本留言簿發(fā)布個(gè)人或團(tuán)體的具有廣告性質(zhì)的信息或類似言論。
ERM/IRMM/BAM歐盟標(biāo)準(zhǔn)品一級(jí)代理,ERM標(biāo)準(zhǔn)物質(zhì)報(bào)價(jià)
USP美國藥典標(biāo)準(zhǔn)品一級(jí)代理,USP標(biāo)準(zhǔn)物質(zhì)報(bào)價(jià)
德國DR標(biāo)準(zhǔn)品一級(jí)代理,DR標(biāo)準(zhǔn)物質(zhì)報(bào)價(jià)
BP英國藥典標(biāo)準(zhǔn)品代理一級(jí)代理,英國BP藥典標(biāo)準(zhǔn)物質(zhì)報(bào)價(jià)
加拿大TRC標(biāo)準(zhǔn)品現(xiàn)貨特價(jià),進(jìn)口藥物標(biāo)準(zhǔn)品代理商
首 頁| 公司介紹| 產(chǎn)品展示| 公司新聞| 技術(shù)文章| 聯(lián)系我們| 客戶留言
阿儀網(wǎng) 設(shè)計(jì)制作,未經(jīng)允許翻錄必究. 聯(lián)系人:程先生 聯(lián)系電話:021-54156088 ICP備案號(hào):滬ICP備17010456號(hào)-2 總訪問量:2911638 管理登錄
主營產(chǎn)品:美國PE耗材、安捷倫耗材、賽默飛熱電耗材 、沃特世耗材、島津耗材、瓦里安耗材
掃一掃,關(guān)注我們!